http://www.fpnotebook.com/
Stress IncontinenceAka: Urinary Stress Incontinence
- Etiologies
- Bladder neck or urethral injury
- Sphincter weakness from neurologic injury
- Decreased Pelvic Floor Competence
- Normal aging
- Surgery
- Multiparity
- Postpartum (20-30% at 3 months postpartum)
- Pathophysiology
- Bladder outlet less than intravesicular pressure
- Weakness of pelvic floor or bladder neck support
- Bladder neck descends below pelvic floor on exertion
- Bladder neck opens
- Only sphincter (weak) can hold back urine
- Symptoms
- Small amounts of urine lost
- Contrast with large volumes in Urge Incontinence
- Urine loss stops immediately after activity stops
- Immediately after increased intrabdominal pressure
- Cough
- Sneeze
- Laugh
- Heaving or straining
- Small amounts of urine lost
- Signs
- Leakage after Valsalva or cough with full bladder
- Weakness or protrusion
- Anterior vaginal wall
- Urethra
- Bladder
- Labs
- Post-void residual under 50 cc
- Bladder Capacity under 400 cc
- Management: General Measures (most effective)
- Kegal Exercises
- Vaginal weight training (Vaginal cones)
- Physical Therapy
- Biofeedback (visualize pelvic floor contractions)
- Functional electrical stimulation
- Transvaginal or Transrectal
- Highly effective in elimination of Incontinence
- Vaginal devices
- Pessaries
- Consider in older patients
- Risk of vaginal infection or local trauma
- Diaphragms
- Bladder support prosthesis
- Used temporarily (e.g. during Exercise)
- Urethral occlusion insert
- Used temporarily (e.g. during Exercise)
- Extracorporeal magnetic innervation (ExMI) chair
- FDA approved chair, 2x/week, 20 minutes, 8 weeks
- Low-intensity magnetic field stimulates pelvis
- Indicated for mild cases that have not had surgery
- Pessaries
- Situational
- Change diet
- Eliminate provocative medications
- Collection or absorption products
- Timed voiding
- Management: Medications
- General
- Medications are not effective in stress Incontinence
- Duloxetine is a possible exception
- Avoid anticholinergics (e.g. Oxybutynin)
- Not effective in stress Incontinence
- Medications are not effective in stress Incontinence
- Duloxetine (Yentreve, Cymbalta)
- SNRI that stimulates urethral sphincter contraction
- Pending FDA approval in 2005
- Topical Estrogen
- Indicated for Postmenopausal Atrophic Vaginitis
- Greater efficacy seen in Urge Incontinence
- Estrogen not effective in stress Incontinence
- Alpha adrenergic agonists
- No strong evidence supporting use
- Preparations
- Phenylpropanolamine
- Pseudoephedrine
- Mechanism
- Increases bladder outlet smooth muscle tone
- Tricyclic Antidepressants (Imiprimine)
- Indications
- Mixed Urge Incontinence and stress Incontinence
- Not indicated in stress Incontinence alone
- Mechanism
- Anticholinergic
- Direct relaxant of detrussor
- Alpha-adrenergic-bladder outlet tone increased
- Indications
- General
- Management: Surgical
- Colposuspension (Elevate UVJ above pelvic floor)
- Effective, but Incontinence may recur with time
- Indicated in Uterine Prolapse
- Tension-free vaginal tape (TVT)
- Urethral sling placed under Local Anesthesia
- More effective than colposuspension
- Collagen injection into periurethral area
- Effective, but Incontinence may recur with time
- Indicated for intrinsic sphincter deficiency
- Colposuspension (Elevate UVJ above pelvic floor)
- References